Class 3 Falsified Medicines Directive (FMD) recall – Beconase Aqueous Nasal Spray 50mcg

12 Feb 2020

A Class 3 FMD recall has been issued by the MHRA for a specific batch of Beconase Aqueous nasal spray

DRUG ALERT

Class 3 Falsified Medicines Directive (FMD) recall – Action within 5 days – Beconase Aqueous Nasal Spray 50mcg

Ref: EL (20)A/07

12 February 2020

Beconase (beclometasone dipropionate) Aqueous nasal spray 50mcg
(Manufactured by Glaxo Wellcome UK Ltd T/A GSK)

PL 10949/0104

A Class 3 FMD recall has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for a specific batch of Beconase Aqueous nasal spray due to an error upon decommissioning.

Batch number Expiry date Pack size First distributed
K84X September 2021 1 6 January 2020

Further information can be found on the MHRA section on the GOV.UK website.

 Produced by the NPA Pharmacy Services team February 2020